Salim Kanoun

5PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyEvolutionary computationVeterinary anaesthesiology and intensive careImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 18, 2023
The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.

Hervé Ghesquières, Daphné Krzisch, Emmanuelle Nicolas-Virelizier

|Jan 08, 2023
Influence of Sociodemographic Determinants on the Hodgkin Lymphoma Baseline Characteristics in Long Survivors Patients Enrolled in the Prospective Phase 3 Trial AHL2011.

Steeve Chevreux, Sandra de Barros, Camille Laurent

|Feb 25, 2022
Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid Lymphomas.

Wendy Revailler, Anne Ségolène Cottereau, Cedric Rossi

|Oct 23, 2021
FDG-PET/CT in Lymphoma: Where Do We Go Now?

Yassine Al Tabaa, Clement Bailly, Salim Kanoun

|May 23, 2018
[18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives.

Salim Kanoun, Cedric Rossi, Olivier Casasnovas

Pageof 1

Frequent Collaborators

2 joint publications

Franck Morschhauser

2 joint publications

Olivier Casasnovas

1 joint publications

Yassine Al Tabaa

1 joint publications

Clement Bailly